Pneumocystis jirovecii in immunocompromised patients with rheumatic diseases

被引：2
|
作者：
Casasempere, Paloma Vela [1 ,2 ]
Torregrosa, Paloma Ruiz [3 ]
Sevila, Raquel Garcia [3 ]
机构：
[1] Hosp Gen Univ Alicante, ISABIAL, Secc Reumatol, Alicante, Spain
[2] Univ Miguel Hernandez, Alicante, Spain
[3] Hosp Gen Univ Alicante, Serv Neumol, Alicante, Spain
来源：
REUMATOLOGIA CLINICA | 2020年 / 17卷 / 05期
关键词：
Pneumocystis jirovecii; Immunosuppression; Rheumatic disease; Autoimmune disease; Prophylaxis; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; DOSE GLUCOCORTICOID THERAPY; CONNECTIVE-TISSUE DISEASES; CARINII-PNEUMONIA; OPPORTUNISTIC INFECTIONS; EULAR RECOMMENDATIONS; CONSENSUS GUIDELINES; RISK-FACTORS; MANAGEMENT;
D O I：
10.1016/j.reuma.2020.02.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Infections, including opportunistic infections, are a major and frequent cause of morbidity and mortality in patients with systemic autoimmune and rheumatic diseases. Pneumocystis jirovecii pneumonia, classically considered to be typical of HIV patients, transplanted patients or patients treated with oncological chemotherapy, is appearing increasingly frequently in these patients. Therefore, rheumatologists should know its mechanism of production, clinical manifestations, treatment and prophylaxis, all of which are addressed in this review. (c) 2020 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.
引用
收藏
页码：290 / 296
页数：7
相关论文
共 50 条
  • [1] Risk Factors of Pneumocystis Jirovecii Pneumonia in Patients with Rheumatic Diseases
    Ekren, P. Korkmaz
    Nesil, I.
    Zihni, F. Yargucu
    Guruz, A.
    Toz, S.
    Turgay, N.
    Sayiner, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [2] Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases
    Braga, Beatriz P.
    Prieto-Gonzalez, Sergio
    Hernandez-Rodriguez, Jose
    [J]. MEDICINA CLINICA, 2019, 152 (12): : 502 - 507
  • [3] PNEUMOCYSTIS JIROVECII INFECTION IN AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES IN OXFORD
    Verdiyeva, Ayna
    Siosi, Alexa Escudero
    Andersson, Monique
    Woodrow, Charles
    Dubey, Shirish
    [J]. RHEUMATOLOGY, 2023, 62
  • [4] Multilocus genotyping of Pneumocystis jirovecii in immunocompromised patients:: Preliminary results
    Costa, Marina C.
    Esteves, Francisco
    Antunes, Francisco
    Matos, Olga
    [J]. JOURNAL OF EUKARYOTIC MICROBIOLOGY, 2006, 53 : 104 - 105
  • [5] Differentiation between pneumocystis jirovecii pneumonia and colonization in immunocompromised patients
    Amal Abd Elazeem Sadon
    Mohamed A. Saraya
    [J]. Egyptian Journal of Bronchology, 2018, 12 (4) : 467 - 472
  • [6] Investigation of Pneumocystis jirovecii Infection and Colonization in Immunocompromised Patients with Pneumonia
    Gulbudak, Harun
    Ozturk, Candan
    Kuyugoz, Sibel
    Ulger, Seda Tezcan
    [J]. MIKROBIYOLOJI BULTENI, 2020, 54 (04): : 583 - 595
  • [7] Pneumocystis jirovecii pneumonia in patients with autoimmune diseases
    Blaas, S.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (09): : 761 - 766
  • [8] Infections with Pneumocystis Jirovecii in Patients with Rheumatoid Diseases
    Vagedes, Daniel
    [J]. AKTUELLE RHEUMATOLOGIE, 2024, 49 (02) : 98 - 102
  • [9] Massive Cavitation by Pneumocystis jirovecii in an Immunocompromised Patient
    Chaar-Hernandez, Aldair
    Montes, Jorge
    Rojas, Maria C.
    Padilla-Mantilla, Diego A.
    Lahmar, Abdelilah
    Toledo-Martinez, Juan F.
    Somoza-Cano, Francisco J.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [10] Radiological Features of Pneumocystis jirovecii Pneumonia in Immunocompromised Patients with and Without AIDS
    Hardak, Emilia
    Brook, Olga
    Yigla, Mordechai
    [J]. LUNG, 2010, 188 (02) : 159 - 163
12345